Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Soff, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Soff, G. A.
[Cancer Research 64, 162-168, January 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Cell Surface-Dependent Generation of Angiostatin4.5

Hao Wang, Ryan Schultz, Jerome Hong, Deborah L. Cundiff, Keyi Jiang and Gerald A. Soff

Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Hematology/Oncology, Chicago, Illinois

Angiostatin4.5 (AS4.5) is a naturally occurring human angiostatin isoform, consisting of plasminogen kringles 1–4 plus 85% of kringle 5 (amino acids Lys78 to Arg529). Prior studies indicate that plasminogen is converted to AS4.5 in a two-step reaction. First, plasminogen is activated to plasmin. Then plasmin undergoes autoproteolysis within the inner loop of kringle 5, which can be induced by a free sulfhydryl donor or an alkaline pH. We now demonstrate that plasminogen can be converted to AS4.5 in a cell membrane-dependent reaction. Actin was shown previously to be a surface receptor for plasmin(ogen). We now show that ß-actin is present on the extracellular membranes of cancer cells (PC-3, HT1080, and MDA-MB231), and ß-actin can mediate plasmin binding to the cell surface and autoproteolysis to AS4.5. In the presence of ß-actin, no small molecule-free sulfhydryl donor is needed for generation of AS4.5. Antibodies to actin reduced membrane-dependent generation of AS4.5 by 70%. In a cell-free system, addition of actin to in vitro-generated plasmin resulted in stoichiometric conversion to AS4.5. Annexin II and {alpha}-enolase have been reported to be plasminogen receptors, but we did not demonstrate a role for these proteins in conversion of plasminogen to AS4.5. Our data indicate that membrane-associated ß-actin, documented previously as a plasminogen receptor, is a key cell membrane receptor capable of mediating conversion of plasmin to AS4.5. This conversion may serve an important role in regulating tumor angiogenesis, invasion, and metastasis, and surface ß-actin may also serve as a prognostic marker to predict tumor behavior.




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
M. Candela, S. Bergmann, M. Vici, B. Vitali, S. Turroni, B. J. Eikmanns, S. Hammerschmidt, and P. Brigidi
Binding of Human Plasminogen to Bifidobacterium
J. Bacteriol., August 15, 2007; 189(16): 5929 - 5936.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. A. Miles, N. M. Andronicos, N. Baik, and R. J. Parmer
Cell-Surface Actin Binds Plasminogen and Modulates Neurotransmitter Release from Catecholaminergic Cells
J. Neurosci., December 13, 2006; 26(50): 13017 - 13024.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wang, J. A. Doll, K. Jiang, D. L. Cundiff, J. S. Czarnecki, M. Wilson, K. M. Ridge, and G. A. Soff
Differential Binding of Plasminogen, Plasmin, and Angiostatin4.5 to Cell Surface {beta}-Actin: Implications for Cancer-Mediated Angiogenesis.
Cancer Res., July 15, 2006; 66(14): 7211 - 7215.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. A. Soff, H. Wang, D. L. Cundiff, K. Jiang, B. Martone, A. W. Rademaker, J. A. Doll, and T. M. Kuzel
In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna
Clin. Cancer Res., September 1, 2005; 11(17): 6218 - 6225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kwon, C.-S. Yoon, W. Jeong, S. G. Rhee, and D. M. Waisman
Annexin A2-S100A10 Heterotetramer, a Novel Substrate of Thioredoxin
J. Biol. Chem., June 24, 2005; 280(25): 23584 - 23592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. P. Michael, G. Sotiropoulou, G. Pampalakis, A. Magklara, M. Ghosh, G. Wasney, and E. P. Diamandis
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
J. Biol. Chem., April 15, 2005; 280(15): 14628 - 14635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.